Convertible Note or Priced Round? A Founder's Framework for Managing Seed-Stage Dilution

For a pre-seed or seed-stage founder, the choice between a convertible note and a priced equity round comes down to one trade-off: speed and simplicity now versus valuation certainty and a predictable cap table later. Convertible notes let you raise without setting a valuation, which Carta notes makes them faster, cheaper, and more flexible than a priced round—but the dilution they create only appears when they convert, sometimes at prices that surprise unprepared founders. This article lays out a decision framework, explains the note terms that drive dilution, works through a conversion calculation, and closes with cap table practices that keep the choice from backfiring. It is not legal, tax, or investment advice, and it covers traditional convertible notes rather than SAFEs.

Convertible Notes vs. Priced Equity Rounds: A Strategic Decision Framework

The two instruments solve different problems. A convertible note is debt that accrues interest and carries a maturity date, meaning it must be repaid or converted into equity by a certain time, as Allied Venture Partners explains. It converts in a future priced round, typically at a discount or based on a valuation cap. A priced equity round sets the company's valuation upfront, issues shares immediately, and gives every party a clear ownership percentage from day one.

The strategic logic follows from that difference. Early-stage startups usually have no market-set valuation, which is precisely why convertibles are popular with angels, seed funds, and founders who want to get moving without a lengthy negotiation. The cost is deferred: as venture firm CRV warns, founders who stack convertible instruments without a conversion model are often caught off guard at their first priced round. Priced rounds invert the trade—more negotiation, legal cost, and investor governance upfront, in exchange for immediate clarity.

Decision Framework: Convertible Note vs. Priced Equity Round

Use this table to weigh the five factors that matter most at seed stage. Read each row against your own situation: if valuation certainty and a clean Series A story dominate, the priced-round column wins; if speed and milestone funding dominate, the note column wins.

Strategic comparison of convertible notes and priced equity rounds for seed-stage founders
Factor	Convertible Note	Priced Equity Round
Valuation Uncertainty	Valuation deferred to a future priced round—simpler now, but future ownership stays uncertain and can become a messy cap table if not tied to clear milestones.	Valuation set upfront, giving all parties immediate clarity on ownership percentages—but requires agreeing on company value very early.
Speed & Legal Cost	Typically faster, cheaper, and more flexible due to simpler documentation and no valuation negotiation. Most effective when tied to defined business milestones.	More complex documentation and extensive negotiation mean higher cost and longer timelines, but the complexity buys structure from the outset.
Investor Scrutiny	Generally lighter scrutiny and fewer governance demands early on, though the debt status and maturity date carry consequences that SAFEs do not.	More robust investor rights and diligence, which slows the process but signals a more underwritten company.
Dilution Impact	Creates "phantom equity" that converts at a discount or valuation cap later—dilution can be significant and lands all at once unless you model scenarios.	Dilution is immediate and clearly understood at the time of the round, since new shares issue at a set valuation.
Control	Fewer governance provisions early; founders retain more operational freedom until conversion.	Often includes board seats and investor rights negotiated upfront, giving investors greater influence but clear expectations for everyone.

The framework's output is a recommendation, not a verdict: a note suits founders who need speed and have a credible story for what the money will change; a priced round suits founders who can defend a valuation and want a stable structure before Series A diligence begins.

Understanding Convertible Note Terms and Dilution Mechanics

Three terms determine what a note does to your cap table. Promise Legal's cap table guidance defines them plainly. The valuation cap is the maximum valuation at which the note converts—it protects early investors if the company's next round prices high. The discount is a reduction, typically 10–20%, to the next round's price, rewarding early risk. The interest rate, typically 2–8% annually, accrues on the note because it is debt; SAFEs carry no interest, which is one reason the two instruments differ despite surface similarity.

Each term creates a different dilution outcome. A cap binds when the next round's valuation exceeds it—the noteholder converts as if the company were worth the cap, buying more shares for the same dollars. A discount binds when the next round prices below the cap—the noteholder converts at, say, 80% of the new investors' price. The noteholder gets whichever mechanism yields the lower conversion price, which is why Allied Venture Partners cautions that conversion "can result in more immediate dilution of ownership" than founders expect. Interest compounds the effect by increasing the balance that converts. A maturity date adds a final constraint: the note must be repaid or converted by a set time.

Worked Example: Calculating Convertible Note Conversion

Here is how the mechanics play out with concrete numbers. Suppose a founder raises $250,000 on a convertible note with a $4 million valuation cap and a 20% discount. Eighteen months later the company raises a $1 million Series A at a $5 million pre-money valuation. Assume, for illustration, 1,000,000 pre-round shares and simple (non-compounding) accrued interest of $25,000, giving a $275,000 conversion balance.

Step 1: Find the noteholder's conversion price. The Series A price per share is $5M ÷ 1,000,000 = $5.00. The discount would give the noteholder $5.00 × 0.80 = $4.00. The cap would give $4M ÷ 1,000,000 = $4.00. The noteholder uses the lower price—here both mechanisms happen to yield $4.00, so the noteholder converts at $4.00 while new money pays $5.00.

Step 2: Compute the shares issued. $275,000 ÷ $4.00 = 68,750 shares to the noteholder. New Series A investors receive $1,000,000 ÷ $5.00 = 200,000 shares.

Step 3: Read the dilution. Post-round the company has 1,268,750 shares. The noteholder holds about 5.4% and new investors about 15.8%. Had the round priced at $4 million instead—below the cap—the discount would have governed, and the noteholder would have converted at 80% of that round's price. The general rule the example illustrates: the lower of the capped price or the discounted next-round price prevails, favoring the noteholder. This is exactly the conversion model CRV says founders skip at their peril.

Best Practices for Proactive Cap Table Management

Whichever instrument you choose, dilution management is an operating discipline, not a fundraising afterthought. Four practices recur across the venture and advisory sources:

Treat modeling as ongoing, not one-time. J.P. Morgan's guidance to founders is blunt: "Treat cap table modeling as an ongoing operating discipline, not a one-time exercise." Re-run conversion scenarios whenever terms change or a round approaches.
Avoid accumulating inconsistent terms. A practitioner quoted in the same guidance observes that "most of the friction I see in the fundraising process comes from complexity that was introduced one note at a time." Stacking notes at different caps and discounts is, per CRV, a common driver of unexpected over-dilution.
Define "fully diluted" precisely. Hustle Fund's investor guide stresses that "there is no safe shortcut here"—one table may include the whole option pool but show convertibles separately; another may fold in estimated conversions. Always name the denominator: outstanding, as-converted, or fully diluted, pre- or post-financing.
Communicate early with stakeholders. Talk to noteholders well ahead of any maturity date as a priced round approaches, and keep the legal record reconciled—issued shares matched to the stock ledger, board approvals, and grant documents.

A note works best, on J.P. Morgan's framing, when it funds progress rather than just time: "Notes should fund progress, not just time." Tie the raise to defined milestones so the next priced round tells a story that justifies the cap and discount you granted.

Making Your Funding Decision: Aligning Strategy with Dilution Management

Founders should choose between a convertible note and a priced equity round by carefully weighing their current valuation certainty, desired fundraising speed, and long-term dilution tolerance, while committing to ongoing cap table management. If you cannot yet defend a valuation and need capital to hit a defined milestone, a note with a single, clearly modeled cap and discount is the pragmatic path. If you can price the round, the upfront cost buys a stable structure and removes conversion risk before Series A diligence.

Either way, the decision is only sound when you can verify it: the founder has a clear, modeled understanding of their projected ownership percentage post-conversion for various scenarios and has established a regular cadence for cap table review and stakeholder communication. That model—re-run before every round and every new note—is the measurable difference between managed dilution and a surprise at the Series A table.